Clinical Trial

Efficacy and Safety of 5% Minoxidil Foam in Female Androgenetic Alopecia

Name: Efficacy and Safety of 5% Minoxidil Foam in Female Androgenetic Alopecia — clinical trial record (NCT07080931)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

The primary objective of this study is to evaluate the efficacy of once-daily 5% minoxidil foam versus placebo in female androgenetic alopecia, using the Target Area Terminal Hair Count (TAHC) as the primary endpoint.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-07-15.

Trial Details

NCT Number	NCT07080931
Lead Sponsor	Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd.
Conditions	Androgenetic Alopecia
Enrollment	294 participants
Start Date	2025-02-24
Primary Completion	2027-12 (estimated)
Study Completion	2027-12 (estimated)
Updated on ClinicalTrials.gov	2026-03-05